GRAIL, Inc. (NASDAQ:GRAL – Get Free Report) was up 6% during trading on Thursday. The stock traded as high as $110.59 and last traded at $108.2520. 110,969 shares traded hands during mid-day trading, a decline of 88% from the average session volume of 961,897 shares. The stock had previously closed at $102.10.
Analyst Upgrades and Downgrades
GRAL has been the subject of a number of analyst reports. TD Cowen raised their price objective on shares of GRAIL from $88.00 to $180.00 and gave the company a “buy” rating in a research report on Tuesday, October 13th. UBS Group upped their target price on shares of GRAIL from $105.00 to $175.00 and gave the stock a “buy” rating in a report on Friday, October 2nd. Piper Sandler increased their target price on shares of GRAIL from $74.00 to $130.00 and gave the stock a “neutral” rating in a research note on Tuesday, November 10th. Wall Street Zen raised shares of GRAIL from a “sell” rating to a “hold” rating in a report on Sunday, September 13th. Finally, Royal Bank Of Canada raised their price target on shares of GRAIL from $84.00 to $100.00 and gave the company a “sector perform” rating in a report on Thursday, November 5th. Five equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, GRAIL currently has a consensus rating of “Hold” and an average price target of $128.80.
Check Out Our Latest Stock Report on GRAIL
GRAIL Stock Performance
The firm has a market capitalization of $4.46 billion, a P/E ratio of -10.43 and a beta of 2.86. The business has a 50 day simple moving average of $123.99 and a two-hundred day simple moving average of $79.76.
GRAIL (NASDAQ:GRAL – Get Free Report) last issued its quarterly earnings results on Wednesday, November 4th. The company reported ($2.21) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($2.45) by $0.24. GRAIL had a negative return on equity of 16.13% and a negative net margin of 243.80%. The firm had revenue of $37.53 million during the quarter, compared to the consensus estimate of $44.21 million. On average, equities analysts anticipate that GRAIL, Inc. will post -9.11 earnings per share for the current fiscal year.
Insider Buying and Selling
In related news, CFO Aaron Freidin sold 23,619 shares of the firm’s stock in a transaction that occurred on Monday, October 5th. The shares were sold at an average price of $146.39, for a total value of $3,457,585.41. Following the sale, the chief financial officer directly owned 225,364 shares of the company’s stock, valued at $32,991,035.96. This trade represents a 9.49% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Andrew Partridge sold 7,873 shares of the firm’s stock in a transaction that occurred on Monday, October 5th. The shares were sold at an average price of $146.39, for a total transaction of $1,152,528.47. Following the completion of the sale, the insider directly owned 155,865 shares in the company, valued at $22,817,077.35. This represents a 4.81% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 132,944 shares of company stock worth $15,155,665. Insiders own 1.83% of the company’s stock.
Institutional Trading of GRAIL
Several institutional investors and hedge funds have recently made changes to their positions in GRAL. BlackRock Inc. lifted its holdings in shares of GRAIL by 20.5% during the 2nd quarter. BlackRock Inc. now owns 3,577,075 shares of the company’s stock worth $244,207,000 after acquiring an additional 608,539 shares during the last quarter. State Street Corp increased its stake in GRAIL by 26.1% in the second quarter. State Street Corp now owns 2,385,514 shares of the company’s stock valued at $162,859,000 after acquiring an additional 493,621 shares during the last quarter. Primecap Management Co. CA bought a new position in GRAIL in the second quarter valued at $148,836,000. Bank of America Corp DE raised its position in GRAIL by 29.0% during the first quarter. Bank of America Corp DE now owns 914,114 shares of the company’s stock valued at $47,241,000 after purchasing an additional 205,611 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its position in GRAIL by 88.5% during the first quarter. Dimensional Fund Advisors LP now owns 408,650 shares of the company’s stock valued at $21,104,000 after purchasing an additional 191,857 shares in the last quarter.
About GRAIL
GRAIL, Inc. is a healthcare company developing blood-based tests for the early detection of multiple cancers. Its approach analyzes patterns in cell-free DNA, including DNA methylation signals, to help identify a possible cancer signal and predict its origin in the body. GRAIL’s flagship product is Galleri, a multi-cancer early detection test intended for use alongside—not as a replacement for—recommended cancer screening. The company also conducts clinical research to evaluate the test and advance its early-detection technology.
Further Reading
- Five stocks we like better than GRAIL
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
- MarketBeat Week in Review – 11/16 – 11/20
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
Receive News & Ratings for GRAIL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GRAIL and related companies with MarketBeat.com's FREE daily email newsletter.
